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Abstract
Toll-like receptor 3 (TLR3) and cytosolic RIG-I-like helicases (RIG-I and MDA5) sense viral RNAs and activate innate immune
signaling pathways that induce expression of interferon (IFN) through specific adaptor proteins, TIR domain-containing
adaptor inducing interferon-b (TRIF), and mitochondrial antiviral signaling protein (MAVS), respectively. Previously, we
demonstrated that hepatitis A virus (HAV), a unique hepatotropic human picornavirus, disrupts RIG-I/MDA5 signaling by
targeting MAVS for cleavage by 3ABC, a precursor of the sole HAV protease, 3Cpro, that is derived by auto-processing of the
P3 (3ABCD) segment of the viral polyprotein. Here, we show that HAV also disrupts TLR3 signaling, inhibiting poly(I:C)-
stimulated dimerization of IFN regulatory factor 3 (IRF-3), IRF-3 translocation to the nucleus, and IFN-b promoter activation,
by targeting TRIF for degradation by a distinct 3ABCD processing intermediate, the 3CD protease-polymerase precursor.
TRIF is proteolytically cleaved by 3CD, but not by the mature 3Cpro protease or the 3ABC precursor that degrades MAVS.
3CD-mediated degradation of TRIF depends on both the cysteine protease activity of 3Cpro and downstream 3Dpol
sequence, but not 3Dpol polymerase activity. Cleavage occurs at two non-canonical 3Cpro recognition sequences in TRIF, and
involves a hierarchical process in which primary cleavage at Gln-554 is a prerequisite for scission at Gln-190. The results of
mutational studies indicate that 3Dpol sequence modulates the substrate specificity of the upstream 3Cpro protease when
fused to it in cis in 3CD, allowing 3CD to target cleavage sites not normally recognized by 3Cpro. HAV thus disrupts both RIG-
I/MDA5 and TLR3 signaling pathways through cleavage of essential adaptor proteins by two distinct protease precursors
derived from the common 3ABCD polyprotein processing intermediate.
Citation: Qu L, Feng Z, Yamane D, Liang Y, Lanford RE, et al. (2011) Disruption of TLR3 Signaling Due to Cleavage of TRIF by the Hepatitis A Virus Protease-
Polymerase Processing Intermediate, 3CD. PLoS Pathog 7(9): e1002169. doi:10.1371/journal.ppat.1002169
Editor: Vincent Racaniello, Columbia University, United States of America
Received March 18, 2011; Accepted June 1, 2011; Published September 8, 2011
Copyright:  2011 Qu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grants U19-AI40035, R21-AI081058 (to SML) and R01-AI69285 (to KL). The funders had no role
in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: smlemon@med.unc.edu
¤ Current address: Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.
Introduction
Hepatitis A virus (HAV) [1] and hepatitis C virus (HCV) [2] are
positive-strand RNA viruses that cause hepatitis in humans.
Despite important differences in virion structure, they share
similar genome structures and many aspects of their replication
strategies. Both viruses demonstrate strong tropism for the
hepatocyte, and replicate their RNA genomes in replicase
complexes contained within cytoplasmic vesicles. Both produce
double-stranded RNA (dsRNA), a potent pathogen-associated
molecular pattern (PAMP) recognized by innate immune sensors,
as replication intermediates. Thus, both HAV and HCV face
similar challenges posed by the innate immune system early in the
course of hepatic infection. However, HAV and HCV infections
have dramatically different outcomes. HAV never causes chronic
hepatitis while HCV does so in the majority of those it infects.
Prolonged shedding of HAV has been reported in premature
infants [3], but long-term persistent infection has never been
documented. This contrasts sharply with HCV, which persists for
decades in the majority of those infected [2,4].
Although factors controlling HCV infection outcome are poorly
understood, T cell responses are critical [reviewed in 2]. T cells also
appear to be important for HAV clearance [5,6]. In both cases, the
vigor and breadth of the virus-specific T response is likely to be
profoundly influenced by early interferon (IFN) and other cytokine
responses evoked by innate antiviral response pathways. How HCV
both induces and disrupts signaling initiated by retinoic acid-
inducible gene I (RIG-I) and Toll-like receptor 3 (TLR3) has been
studied in depth. Proteolytic cleavage of mitochondrial antiviral
signaling protein (MAVS, also known as IPS-1, VISA or Cardif) and
TIR domain-containing adaptor inducing IFN-b (TRIF, also
known as TICAM-1) by the NS3/4A serine protease of HCV
effectively blocks the activation of IFN-regulatory factor 3 (IRF-3)
and nuclear factor-kB (NF-kB) induced by RIG-I and TLR3,
respectively [7,8,9]. Much less is known about how HAV stimulates
or antagonizes these innate signaling pathways.
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Both clinical and experimental observations indicate that there
is extensive replication of HAV within the liver prior to the onset
of hepatic inflammation 3–4 weeks after infection [10]. This
lengthy, clinically silent incubation period suggests that HAV
either blocks or otherwise fails to induce innate immune responses
to dsRNA in the early stages of the infection. Consistent with this,
HAV, like HCV, disrupts virus-induced signaling initiated by
RIG-I-like receptors (RLRs, RIG-I and melanoma differentiation
associated gene 5, MDA-5) [11,12]. Our previous work shows that
it does this by targeting MAVS for proteolysis by a precursor of its
3Cpro cysteine protease, 3ABC [12]. Cleavage requires both the
protease activity of 3Cpro and a transmembrane domain in 3A that
directs 3ABC to the mitochondrial outer membrane where MAVS
is localized [12]. The shared capacity of the HAV 3ABC and
HCV NS3/4A proteases to cleave MAVS and disrupt signaling
from RLRs suggests that MAVS-dependent signaling is critical to
antiviral defense in the liver (as it is in other tissues), but also
indicates that NS3/4A cleavage of MAVS is not primarily
responsible for the unique ability of HCV to establish persistent
infections.
In addition to RLRs, TLR3 is functionally expressed in primary
human hepatocytes [13]. During HCV infection, signaling
initiated by TLR3 recognition of dsRNA is blocked by NS3/4A
cleavage of the adaptor protein, TRIF [7,13]. This led us to ask
whether HAV also antagonizes TLR3 signaling. We show here
that HAV strongly inhibits TLR3 signaling by also targeting TRIF
for degradation. We demonstrate that TRIF is proteolytically
cleaved by a distinct intermediate in the polyprotein processing
cascade, the viral 3CD protease-polymerase. Cleavage requires
expression of the cysteine protease activity of 3Cpro fused in cis to
3Dpol sequence. Mutational studies reveal an unexpected role of
the 3Dpol domain in modulating the substrate specificity of 3Cpro
such that it is able to achieve scission of non-canonical 3Cpro
cleavage sites within TRIF. The role played by the polymerase
sequence in innate immune evasion represents a remarkable and
unique mechanism of viral adaptation to the intrahepatic
environment, and provides a second major evasive strategy by
which HAV can escape innate immunity.
Results
HAV inhibits TLR3 signaling by reducing abundance of
the adaptor protein TRIF
Although hepatocytes express TLR3, Huh7 hepatoma cells,
which are permissive for replication of cell culture-adapted HAV,
are defective in TLR3 signaling [14,15]. We therefore studied the
impact of HAV infection on TLR3 signaling in Huh7 cells in
which signaling was functionally reconstituted by retroviral
transduction of TLR3 expression [13]. Previous studies of these
cells include extensive control experiments showing that the
activation of IRF-3 by extracellular poly-(I:C) occurs specifically
through TLR3 signaling [13]. Control cells used in here included
Huh7 cells transduced in parallel with a TIR-domain TLR3
deletion mutant or empty vector. Stimulation of Huh7-TLR3 cells
with extracellular poly(I:C), a synthetic dsRNA analog, induced
transcriptional activation of the IFN-b promoter and expression of
the interferon-stimulated gene (ISG) ISG15, neither of which were
observed in Huh7-DTIR or Huh7-Vector cells (Fig. 1A, B).
However, prior infection of Huh7-TLR3 cells with HM175/18f, a
cell culture-adapted HAV variant [16], strongly inhibited both
responses (Fig. 1A, B). The expression levels of TLR3 and its
DTIR mutant were not affected by HAV (Fig. 1B), suggesting that
HAV does not disrupt TLR3 signaling by reducing TLR3
abundance. HAV inhibition of TLR3 signaling was also observed
in Huh7.5-TLR3 cells, TLR3-reconstituted Huh-7.5 cells that are
deficient in RIG-I signaling (Fig. S1A in Text S1) [13].
The IFN-b promoter is activated by overexpression of the
TLR3 adaptor protein, TRIF, or downstream kinases, TBK-1 or
IKKe, that phosphorylate IRF-3 [17]. In HAV-infected cells,
however, its activation by TRIF was reduced by about 50%, while
there was no reduction in its stimulation by IKKe (Fig. 1C). This
result is similar to that reported previously by Fensterl et al. [11].
We also observed a marked reduction in the abundance of IRF-3
dimers in HAV-infected Huh7-TLR3 cells stimulated with
extracellular poly-(I:C) (Fig. 1D). In addition, confocal microscopy
revealed that IRF-3 did not undergo nuclear translocation upon
poly-(I:C) stimulation of HAV-infected Huh7-TLR3 cells (Fig. 1E),
while this occurred uniformly in uninfected cells (Fig. S1B in Text
S1, right panel). Importantly, HAV infection itself induced neither
IRF-3 dimerization (Fig. 1D) nor nuclear translocation (Fig. S1B
in Text S1, left panel), indicating an absence of IRF-3 activation.
Collectively, these results indicate that HAV infection disrupts the
signal transduction pathway from TLR3 prior to the kinases
responsible for IRF-3 activation.
Consistent with a defect in signaling at this level, we found the
abundance of endogenous TRIF was substantially reduced in
HAV-infected Huh7 or Huh7.5-TLR3 cells (Fig. 2A). In addition,
we could not detect TRIF in a stable Huh7 cell line harboring an
autonomously replicating subgenomic HAV replicon (HAV-Bla
cells) [18], while TRIF expression was restored after eliminating
the replicon by IFN treatment (Bla-C cells, Fig. 2B). Thus, HAV
infection disrupts TLR3 signaling by substantially decreasing the
expression of TRIF.
The HAV 3CD protease-polymerase processing
intermediate disrupts TLR3 signaling by cleaving TRIF
To determine whether a specific HAV protein or polyprotein
processing intermediate was responsible for the reduction in TRIF
abundance and, as a result, the inhibition of TLR3 signaling, we
over-expressed individual proteins in Huh7-TLR3 cells, assessing
the impact on poly(I:C)-induced, TLR3-dependent activation of
the IFN-b promoter. While ectopic expression of the P1-2A
structural proteins (P1-2A, VP0, VP3, VP1-2A) and 2B or 2C had
Author Summary
While viruses that target the liver often cause lengthy
infections with considerable morbidity, there is limited
understanding of how they evade host responses. We have
studied hepatitis A virus (HAV), an important cause of
acute hepatitis in humans. Although HAV infection
typically results in hepatic inflammation, there is no
disease in the liver during the first weeks of infection
despite robust virus replication. This suggests that HAV
either fails to stimulate or efficiently evades recognition by
host innate immune sensors. Our prior work showed HAV
disrupts RIG-I/MDA5 signaling by targeting MAVS, an
essential adaptor protein, for degradation by 3ABC, a
precursor of the only HAV protease, 3Cpro. Here, we show
here that a distinct viral processing intermediate, the 3CD
protease-polymerase, disrupts TLR3 signaling by degrad-
ing its adaptor protein, TRIF. HAV has evolved a novel
strategy to target two different host adaptor proteins with
a single protease, using its 3Dpol RNA polymerase to
modify the substrate specificity of its 3Cpro protease when
fused to it in the 3CD precursor, thus allowing it to target
non-canonical 3Cpro recognition sequences in TRIF. This
remarkable example of viral adaptation allows the virus to
target two different host adaptor proteins with a single
viral protease.
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little impact on TLR3 signaling, the processing intermediate
3ABCD and its 3CD protease-polymerase derivative strongly
blocked promoter activation (Fig. 3A, top panel). An intermediate
degree of suppression was observed with 2BC and 3Cpro
expression. The effect of 2BC on signaling may be related to its
capacity to induce intracellular membrane rearrangement [19],
and was not studied further.
The common presence of the 3Cpro cysteine protease domain in
3ABCD, 3CD and 3Cpro suggested it may play a role in disrupting
TLR3 signaling. However, 3Cpro alone was significantly less
inhibitory than either 3CD or 3ABCD (Fig. 3A, top panel,
p,0.002 by Student’s t test), despite being expressed in much
greater abundance (Fig. 3A, lower panel). Since 3ABCD is the
precursor of 3CD, its inhibitory effect on TLR3 signaling could be
due entirely to 3CD. 3ABC, which is also derived from 3ABCD
and targets MAVS for cleavage [12], had no effect. Consistent
with these results, the co-expression of 3CD, but not 3Cpro or
3Dpol, or a combination of these two proteins, resulted in a marked
reduction of ectopically expressed TRIF in HEK 293FT cells (in
which endogenous TRIF expression is negligible) (Fig. 3B). The
reduced abundance of full-length TRIF in cells expressing 3CD
was accompanied by the appearance of two TRIF fragments with
apparent molecular masses of 75 and 55 kDa that were detected
by an antibody recognizing residues surrounding Ser-219 (Fig. 3B,
open triangles). Since full-length TRIF has a mass of ,90-kDa,
these are likely to be overlapping degradation products. An
antibody to residues 4–31 of TRIF identified an additional
fragment with an apparent mass of 20 kDa, likely derived from the
N-terminus of TRIF (not shown). The accumulation of at least
three different fragments suggests that 3CD causes multiple
scission events within TRIF. 3CD-mediated cleavage of TRIF
was not dependent upon the cell culture-adaptive mutations
Figure 1. HAV inhibits TLR3 signaling prior to IRF-3 phosphorylation and nuclear translocation. (A) IFN-b-Luc reporter assay of Huh7-
TLR3, Huh7-DTIR, and Huh7-Vector cells that were mock- or HAV-infected (m.o.i. = 3) for 5 days and stimulated with extracellular poly(I:C) for 6 hours.
Luciferase activity was normalized to an internal b-gal transfection control and is presented fold-induction by poly(I:C). (B) Immunoblots of the cells in
panel (A) showing expression of TLR3 and TLR3-DTIR (top panel), HAV 3ABC and 3Cpro (middle panel), and poly(I:C)-induced ISG15 (bottom panel). (C)
IFN-b-Luc reporter assay of poly(I:C), TRIF, or IKKe-induced activation of the IFN-b promoter in mock- or HAV-infected Huh7-TLR3 cells. (D) HAV
infection blocks poly-(I:C)-induced dimerization of IRF-3 in Huh7/TLR3 cells. (top panel) Immunoblot of IRF-3 in extracts of HAV- or mock-infected cells
resolved by native PAGE. Cells were lysed 2 hrs after addition of poly-(I:C) (50 mg/ml) to media. IRF-3 dimers are indicated by the arrowhead. (bottom
panel) Immunoblot of native PAGE with 3Cpro-specific antibody. (E) Laser-scanning confocal microscopy images of Huh7-TLR3 cells infected with HAV
at low m.o.i. for 5 days and stimulated with poly-(I:C). Cells were labeled with antibodies to IRF-3 (red) and HAV (green), while nuclei were
counterstained with DAPI (blue). The merged image on the right shows that IRF-3 has undergone nuclear translocation in two uninfected (‘u’, see
middle panel) cells, but not in an infected cell (‘i’) containing HAV antigen.
doi:10.1371/journal.ppat.1002169.g001
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Figure 2. TRIF abundance is reduced by HAV infection. (A) (top panel) Endogenous TRIF in mock- or HAV-infected Huh7 and Huh7.5-TLR3 cells
was immunoprecipitated using a rabbit anti-TRIF antibody [7] and detected by immunoblotting. (middle panel) HAV infection was confirmed by
immunoblot of viral proteins 3ABC and 3Cpro. (bottom panel) Actin served as loading control. (B) Endogenous TRIF and 3ABC expression in the HAV
replicon HAV-Bla cells and IFN-a-cured Bla-C cells [12] (top). TRIF was detected as in panel A. ‘*’ indicates a nonspecific protein band.
doi:10.1371/journal.ppat.1002169.g002
Figure 3. The HAV 3CD protease-polymerase precursor disrupts TLR3 signaling through cleavage of TRIF. (A) (top panel) IFN-b-Luc
reporter assay of Huh7.5-TLR3 cells transfected with expression vectors encoding HA-tagged HAV proteins and stimulated with extracellular poly(I:C).
(bottom panel) Extracts of similarly transfected cells were analyzed by immunoblotting with HA antibody to detect HAV proteins (solid star, middle
panel), or with specific antibody to 3Cpro (open star, bottom panel). ‘*’ indicates a nonspecific protein band. 3CD and 3Dpol were not visualized with
any antibody. (B) HEK 293FT cells were co-transfected with vectors expressing TRIF and HA-tagged HAV proteins. Cell lysates were analyzed by
immunoblotting for TRIF (top) or 3Cpro and 3CD (bottom). In addition to the 90-kDa full-length TRIF, two TRIF fragments, 75- and 55-kDa in size (‘D’),
were detected in cells expressing 3CD. A nonspecific protein band detected by TRIF antibody (‘*’) indicates equal loading. (C) IFN-b-Luc and PRD-II-
Luc (NF-kB specific) reporter assays of Hela cells transfected with control or 3CD expression vectors and stimulated with extracellular poly(I:C).
Increasing amounts of 3CD expression vector (50 ng and 100 ng) were used.
doi:10.1371/journal.ppat.1002169.g003
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present in the 3CD sequence of the HM175/18f virus [16] used in
these studies, as it was also observed with ectopically expressed,
wild-type 3CD (Fig. S3 in Text S1). Consistent with these
observations, 3CD overexpression resulted in a marked reduction
in poly-I:C-stimulated IFN-b and PRD-II (NF-kB-responsive)
promoter activity in HeLa cells (Fig. 3C). Thus, 3CD effectively
antagonizes an endogenous TLR3 pathway, as well as the
reconstituted pathway in Huh7-TLR3 cells.
Since co-expression of 3Cpro and 3Dpol did not result in
detectable TRIF cleavage (Fig. 3B), efficient scission appears to
require expression of the protease and polymerase domains in cis.
3CD is known to be a catalytically active precursor of 3Cpro [20],
thus 3CD could directly cleave TRIF. To test this hypothesis, we
expressed a 3CD mutant with an Ala substitution of the active-site
nucleophile, Cys-172 (Fig. 4A). This lacked any capacity to cleave
ectopically expressed TRIF (Fig. 4B), confirming that the protease
activity of 3CD is responsible. In contrast, a mutant in which the
conserved GDD motif required for RNA-dependent RNA
polymerase activity was ablated (3CD-GAA) remained capable
of cleaving TRIF. The 3CD-GAA mutant also inhibited poly(I:C)-
induced activation of the IFN-b promoter in Huh7-TLR3 cells,
whereas the proteinase-deficient 3CD-C172A mutant did not
(Fig. 4C). Collectively, the results shown in Figs. 3 and 4 indicate
that TRIF cleavage results from the 3Cpro protease acting in cis
with 3Dpol.
To assess whether TRIF is cleaved by a 3Cpro–3Dpol complex
forming after auto-processing of 3CD, we constructed 3CD
mutants with modifications at the 3C–3D junction that accelerate
or retard autoprocessing. The 3C–3D junction is comprised of a
primary 3Cpro cleavage site, IESQQR, and an alternative cleavage
site, EFTQQC, separated by 9 residues (Fig. S2A in Text S1). In
one mutant, 3CD-QQRR, both cleavage sites were abolished by
Figure 4. 3CD cleavage of TRIF requires both 3Cpro protease activity and 3Dpol in cis. (A) Organization of 3CD, showing the position of Cys-
172 at the 3Cpro active site and the GDD polymerase motif in 3Dpol. (B) Huh7 cells were co-transfected with vectors expressing TRIF and 3C, 3D, or
3CD, as indicated. Cell extracts were analyzed by immunoblotting for TRIF. TRIF cleavage fragments are marked (‘D’). A nonspecific protein band
detected by TRIF antibody (‘*’) indicates equal loading. (C) IFN-b-Luc reporter assay of Huh7-TLR3 cells transfected with vectors expressing 3CD or the
related C172A and GAA mutants, and stimulated with extracellular poly-(I:C). (D) Alignment of 3Cpro consensus cleavage sequence and possible
cleavage sites in TRIF (left), and locations of these sites relative to the TRAF6-binding motifs (open star) and TIR and RHIM domains (grey boxes)
within TRIF (right). (E) Identification of Q190 and Q554 as 3CD cleavage sites in TRIF. HEK 293FT cells were co-transfected with vectors expressing TRIF
mutants and 3CD, and cell extracts were analyzed by immunoblotting of TRIF. TRIF cleavage fragments and a nonspecific protein band were marked
as in (B). A TRIF degradation band (solid triangle), independent of 3CD cleavage, was occasionally observed. (F) A model for 3CD cleavage of TRIF.
Cleavage at the preferred primary Q554 site induces a conformational change that exposes the Q190 site for the second cleavage.
doi:10.1371/journal.ppat.1002169.g004
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Gln-to-Arg mutations such that expression resulted only in the
3CD precursor (Fig. S2B in Text S1). In the other, 3CD-LWG, the
primary cleavage site was optimized to LWSQQG, making it
identical to the efficiently cleaved 2C–3A junction (Fig. S2A in
Text S1). Expression of 3CD-LWG led to less 3CD precursor, and
a greater abundance of mature 3Cpro due to enhanced 3C/3D
processing (Fig. S2B in Text S1). While the 3CD-QQRR mutant
remained capable of cleaving TRIF, the hyper-processing 3CD-
LWG mutant did not (Fig. S2C in Text S1). We conclude that the
cleavage of TRIF results from the cysteine protease activity of the
unprocessed 3CD sequence.
TRIF is cleaved by cellular caspases at residues D281 and D289
under conditions favoring apoptosis, including over-expression of
TRIF [21]. This generates a 38-kDa fragment that is distinct from
those generated by 3CD (Fig. S4A in Text S1). Moreover, a
D281E-D289E (DDEE) TRIF mutant resistant to caspase
cleavage [21] remained subject to cleavage by 3CD (Fig. S4A in
Text S1). Thus, TRIF is not degraded indirectly by cellular
caspases when 3CD is expressed. While a broadly active caspase
inhibitor, z-VAD-fmk, partially inhibited the 3CD-mediated
cleavage of TRIF (Fig. S4B in Text S1), z-VAD-fmk is known to
inhibit cellular proteases other than caspases that, like 3Cpro,
contain cysteine nucleophiles [22].
To show that TRIF is cleaved directly by the viral protease, we
attempted to purify GST-3CD and GST-3Cpro fusion proteins
produced in E. coli. The GST-3CD fusion product formed an
insoluble pellet upon extraction, precluding its purification. This
likely reflects the extreme insolubility of 3Dpol, which has hindered
previous efforts to purify the HAV polymerase [23]. We were able
to produce purified GST-3Cpro. In cell-free cleavage assays, this
demonstrated a limited ability to process [35S]-labeled TRIF
prepared by in vitro translation (Fig. S5 in Text S1), but did
produce the expected ,75-, ,55-, ,27-, and ,18-kDa cleavage
products when incubated with full-length TRIF, or fragments
representing amino acids 1–372 or 373–712 of TRIF, in vitro (Fig.
S5B in Text S1). Taken collectively with the data shown in Fig. S4
in Text S1, these results confirm that TRIF cleavage is caused by
the HAV protease directly, and not by indirect activation of a
caspase or other cellular protease. The incomplete proteolysis of
TRIF observed in the cell-free cleavage reactions is consistent with
the partial inhibition of IFN-b promoter activation by poly-(I:C)
we observed following high-level expression of 3Cpro in Fig. 3A.
Thus, while 3Cpro is capable of cleaving TRIF, its capacity to do so
is much less than 3CD.
3CD cleaves TRIF at Gln-190 and Gln-554 in an ordered
process
We next examined the sequence of human TRIF for potential
3Cpro cleavage sites. Previous studies of 3Cpro substrate specificity
have documented a preference for Gln at the P1 position and a
consensus sequence (L,V,I)X(S,T)QQX where X is any amino
acid [24]. The 3ABC cleavage site in MAVS, LASQQV, fits this
consensus perfectly [12]. In contrast, TRIF does not contain any
consensus 3Cpro cleavage sites, although several sites are partial fits
that could serve as non-canonical cleavage sites with consensus P1
and P2 resides. We focused on two clusters of such sites (Fig. 4D)
that could potentially generate cleavage fragments of appropriate
size (75, 55, and 20 kDa, see above). We constructed a series of
mutants in which the invariant Gln at each potential P1 position
was substituted with Arg, and examined their cleavage by 3CD.
3CD cleavage was not affected by Q211R, Q581R-Q583R, or
Q612R mutations (Fig. 4E, left), excluding these as 3CD cleavage
sites. In contrast, a Q190R mutation blocked the cleavage event
that generates the 55 kDa but not the 75 kDa fragment, while
Q552R-Q554R mutations completely abolished 3CD cleavage of
TRIF (Fig. 4E, left). We then constructed individual Q552R and
Q554R mutants, and showed the loss of cleavage in Q552R-
Q554R was due to Q554R (Fig. 4E, right). These results establish
Q190 and Q554 as 3CD cleavage sites within TRIF, and clarify
the identities of the observed TRIF cleavage fragments. The
75 kDa fragment results from cleavage at Q554 and corresponds
to aa 1–554 of TRIF. This fragment is further cleaved at Q190,
giving rise to the 55-kDa and 20-kDa fragments that correspond to
aa 191–554 and 1–190, respectively.
The different effects of the Q190R and Q554R mutations on
3CD cleavage of TRIF indicate that 3CD cleaves TRIF in an
ordered process. The fact that cleavage at Q190 cannot proceed
when cleavage at Q554 is blocked (Fig. 4E) suggests that the
cleavage at Q554 is a prerequisite to cleavage at Q190. We thus
propose a ‘‘two-step’’ model for the 3CD cleavage of TRIF, in
which primary cleavage at Q554 site induces a conformational
change that exposes the Q190 site, allowing the second cleavage to
occur (Fig. 4F).
The N-terminal region of TRIF contains three TRAF6-binding
motifs that are important for activation of the transcription factors
NF-kB and IRF-3 in TLR3 signaling [25,26]. Q190 is located
between the first and second of these TRAF6-binding motifs, while
the Q554 cleavage site is located between the TIR domain and
RHIM motif (Fig. 4D, right), both important for transcriptional
activation of IFN-b [27]. Cleavage at these residues could yield
fragments with reduced signaling ability, or potentially dominant
negative activity against signal transduction. We thus ectopically
expressed the predicted, individual 3CD-generated TRIF frag-
ments: N-190 (aa 1–190), N-554 (aa 1–554), M-364 (aa 191–554)
and C-158 (aa 555–712) (Fig. S6A in Text S1), and examined their
abilities to activate IFN-b and NF-kB-specific (PRD-II) promoters
in luciferase reporter assays. While N-190 and C-158 were
incapable of activating either promoter, overexpression of N-554
and M-364 stimulated both the IFN-b and PRD-II promoters (Fig.
S6B in Text S1, left and right, respectively). When co-expressed
with wild-type TRIF at a 1:1 ratio, these fragments did not
demonstrate any dominant negative effects (Fig. S6C in Text S1).
Other evidence suggests they do not transduce signals from TLR3
(data not shown).
Altered substrate specificity of 3CD contributes to TRIF
cleavage
We next addressed the question of why TRIF is cleaved by 3CD
but very inefficiently or not at all by 3Cpro. The ability of 3ABC to
cleave MAVS, while 3Cpro cannot, is related to its unique
mitochondrial targeting [12]. To determine if differences in
intracellular localization could similarly account for the unique
activity of 3CD, we compared the cellular localization of 3Cpro
and 3ABCD by confocal microscopy. When expressed ectopically
with an N-terminal Flag tag, 3Cpro was diffusely present
throughout the cytoplasm, while Flag-3ABC, included as a
control, demonstrated prominent mitochondrial localization, as
reported previously [12] (Fig. 5A). In contrast, 3ABCD, expressed
with a C-terminal V5 tag, was present at much lower abundance
and with a perinuclear, ER-like distribution. Both 3CD and
3ABCD are known to be subject to ubiquitin-mediated proteolysis
[28], potentially explaining the low abundance of 3ABCD-V5,
much of which is likely processed to 3CD or 3Dpol. Confocal
microscopy of cells ectopically expressing both TRIF and
proteolytically-inactive C172A mutants of 3Cpro and 3CD
revealed no evidence for specific co-localization of these proteins
(Fig. 5B). Thus, the unique ability of 3CD to cleave TRIF is not
due to its localization to a TRIF-rich compartment.
Disruption of TLR3 Signaling by Hepatitis A Virus
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The noncanonical nature of the 3CD cleavage sites in TRIF,
DWSQ190 and EQSQ554, in which the P4 position is occupied by
an amino acid residue with an acidic (Asp or Glu) rather than
hydrophobic side chain (Leu, Ile or Val) (Fig. 5C), could explain
why TRIF is not efficiently cleaved by 3Cpro. The fact that they
are nonetheless cleaved by 3CD suggests that the substrate
specificity of 3CD may differ from that of 3Cpro in tolerating or
possibly preferring an acidic residue at the P4 position. To assess
this potential difference in substrate specificity, we altered the P4
positions within the non-canonical cleavage sites in TRIF,
substituting the acidic P4 residues in each with Leu, thereby
generating consensus 3Cpro sites (TRIF-D187L and TRIF-E551L,
respectively, Fig. 5C). When expressed ectopically, the D187L
mutant, now carrying a LWSQ cleavage sequence, was readily
processed by both 3Cpro and 3CD, yielding a novel fragment with
an apparent molecular mass of 70 kDa (Fig. 5D, lane 5, 6). This
70 kDa fragment co-migrated in SDS-PAGE with the TRIF C-
522 fragment corresponding to aa 191–712 (Fig. 5D, compare
lane 5 vs. 14), confirming that cleavage had occurred at Q190. As
expected, this fragment was not further cleaved by 3Cpro, but was
further processed by 3CD at Q554, generating the same 55 kDa
fragment produced from wild-type TRIF by 3CD (Fig. 5D, lane 3
Figure 5. Altered substrate specificity of 3CD contributes to TRIF cleavage. (A) Confocal immunofluorescence microscopic images showing
subcellular localization of Flag- or V5-tagged 3Cpro, 3ABCD and 3ABC (green), merged with DAPI (blue) staining of nucleus (top) and additional
MitoTracker (red) staining of mitochondria (bottom). (B) Confocal immunofluorescence microscopic images of cells expressing C-terminally Flag-
tagged full-length TRIF and N-terminally HA-tagged protease-inactive mutant (C172A) forms of 3Cpro and 3CD. No co-localization is evident between
3Cpro or 3CD proteins and TRIF. (C) Alignment of the 3Cpro consensus cleavage sequence and TRIF 3CD cleavage sites. The P4 positions at the Q190
and Q554 cleavage sites (D187 and E551, respectively) were substituted with the 3Cpro-preferred Leu (underlined) in the D187L, E551L and DELL
(D187L-E551L) double mutant. (D) Cleavage of TRIF mutants by 3Cpro and 3CD. HEK 293FT cells were co-transfected with vectors expressing TRIF
mutants and 3Cpro or 3CD (lane 1 to 12), or transfected with full-length or truncated TRIF constructs corresponding to the cleavage fragments (lane
13–16). Cell extracts were analyzed by immunoblotting of TRIF. The D187L mutant and DELL double mutant were cleaved by both 3Cpro and 3CD,
resulting in intermediate cleavage fragments (solid triangle) different from that of 3CD-cleaved wild-type (WT) TRIF (open triangle, 75-kDa), but the
end product was the same (open triangle, 55-kDa). A nonspecific protein band (‘*’) detected by TRIF antibody indicates equal loading. (E) Schematic
showing TRIF fragments created by different cleavage order at Q190 vs. Q554, corresponding to cleavage fragments observed in (C) and (D).
doi:10.1371/journal.ppat.1002169.g005
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vs. 6). On the other hand, there was no difference in the processing
of the wild-type and the E551L mutant TRIF, the latter of which
was only marginally cleaved by 3Cpro despite carrying a canonical
LQSQ sequence (Fig. 5D, lane 7 vs. 8). Nonetheless, when both
cleavage sites were changed to a 3Cpro consensus, the resulting
double mutant (TRIF-DELL) was readily cleaved by both 3Cpro
and 3CD (Fig. 5D, lanes 11 and 12). This produced a 70 kDa
fragment similar to that observed with the D187L mutant,
suggesting that the order of cleavage had been altered to occur
first at Q190 (Fig. 5E). Additional processing led to the 55 kDa
fragment, although there was less of this product produced by
3Cpro than 3CD. Collectively, these results demonstrate that 3CD
differs in its substrate specificity from 3Cpro, tolerating an acidic
residue at the P4 position while 3Cpro does not, and that this
accounts, at least in part, for its ability to cleave TRIF.
TLR3 signaling and cellular permissiveness to HAV
The ability of HAV to antagonize TLR3 signaling is likely to
have evolved because antiviral responses evoked by TLR3 act in
someway to restrict infection. To test this hypothesis, we assessed
viral replication by a variety of methods over a range of
multiplicity of infection. Immunoblots demonstrated that viral
protein abundance (3Cpro) was reduced in Huh7.5-TLR3 cells
infected at an m.o.i. of 3, compared to cells expressing empty
vector or TLR3-DTIR (Fig. 1B, lane 4 vs. lanes 2 or 6). Similarly,
the fluorescence intensity of HAV antigen was noticeably less in
infected Huh7.5-TLR3 cells compared with the control DTIR
cells (Fig. 6A), although the proportion of cells expressing HAV
antigen was not reduced 5 days after infection at an m.o.i. of 1.
HAV antigen-specific ELISA assays also showed that Huh7.5-
TLR3 cells (infected at an m.o.i. of 0.05) produced less than 50%
of the amount of assembled HAV capsid antigen produced by cells
expressing empty vector, or a TLR3 mutant incapable of binding
dsRNA (TLR3-H539E) [13] (Fig. 6B). Infectious virus yields were
also reduced (by 30–60%) in Huh7.5-TLR3 cells infected at low
m.o.i. (Fig. 6C).
Somewhat different results were obtained in one-step growth
assays done at an m.o.i. of 5.0. HAV replicates very slowly
compared to other picornaviruses, with an infectious cycle of
approximately 24 hrs evident in such assays (Fig. 6D). Somewhat
surprisingly, we observed no differences in the kinetic of
intracellular infectious virus accumulation between Huh7.5-
TLR3 vs. H539E cells, up to 24 hrs after inoculation of the cells
under one-step growth conditions (Fig. 6D, left). Subsequent to this
time point, however, less virus was produced in cells expressing
functional TLR3. This restriction on virus replication was also
reflected in slightly lower (about half log10) yields in extracellular
infectious virus released from the cells (Fig. 6D). Collectively, these
data suggest that TLR3 signaling imposes a modest restriction on
HAV infection, particularly at low m.o.i., and after the first round
of viral RNA replication. This is reminiscent of the effects of TLR3
expression on low vs. high m.o.i. HCV infections that we have
observed in previous studies [13].
To confirm these findings, we sought evidence of a gain in
permissiveness for HAV infection in PH5CH8 cells in which
TLR3 signaling was impaired by RNAi-mediated depletion of
TRIF. PH5CH8 cells are T-antigen transformed adult human
hepatocytes that possess robust TLR3 and RLR signaling [14] and
are generally nonpermissive for HAV. TRIF was depleted by
lentiviral transduction of a TRIF-specific short-hairpin RNA
(shRNA) (Fig. 6E), eliminating IFN-b promoter activation by
extracellular poly-I:C (Fig. 6F). The cells were infected with HAV
at an m.o.i. of 1, and examined 8 days later by immunofluores-
cence microscopy for viral antigen expression. This was rarely
observed in PH5CH8 cells transduced with a non-targeting
control shRNA, but detected in ,2% of the TRIF depleted cells
(Fig. 6G). Similar results were obtained in cells transduced with a
TLR3-specific shRNA (data not shown).
Thus, reconstitution of TLR3 signaling in Huh7.5 cells results in
a modest inhibition of HAV infection, while the ablation of TLR3
signaling in PH5CH8 cells provides a significant replication
advantage to HAV. In both cases, these effects are of relatively
small magnitude, likely reflecting the presence of redundant innate
antiviral defense mechanisms, including responses generated by
RLRs or protein kinase R. The abrogation of pro-inflammatory
signals, the effects of which cannot be deduced from in vitro
experiments, may represent a more substantial advantage to the
virus in vivo in HAV-infected persons.
Discussion
Here, we show that HAV disrupts TLR3 signaling by targeting
the essential adaptor protein TRIF for degradation by the 3CD
protease-polymerase processing intermediate. The ability of poly-
I:C to stimulate the IFN-b promoter or induce the expression of
ISGs when added to media was markedly attenuated in HAV-
infected Huh7 hepatoma cells in which TLR3 expression had
been reconstituted by retroviral gene transduction (Fig. 1A and B).
This disruption of TLR3 signaling was associated with a loss of
detectable TRIF (Fig. 2), and could be recapitulated by ectopic
expression of 3ABCD or 3CD in both Huh7-TLR3 cells and
HeLa cells which possess an endogenous TLR3 signaling pathway
(Fig. 3). The loss of TRIF expression was linked to the cysteine
protease activity residing within the 3C sequence of 3CD, which
we demonstrate cleaves TRIF sequentially at two noncanonical
3Cpro cleavage sites (Fig. 4B and E). Additional studies suggested
that this is due to the ability of the 3D sequence in 3CD to alter the
substrate specificity of the protease such that it better accommo-
dates the acidic residues present at the P4 position of cleavage sites
in TRIF (Fig. 5D). These observations add to our understanding of
the pathogenesis of HAV, a significant human pathogen that has
received scant attention in recent years.
In previous work, we demonstrated that HAV also antagonizes
the induction of IFN responses by the cytosolic RLR pattern
recognition receptors, RIG-I and MDA-5, by inducing proteolysis
of the adaptor protein MAVS [12] (Fig. 7). As we report here with
poly-I:C-induced TLR3 signaling, we found that ectopically
expressed 3ABCD was capable of disrupting Sendai virus-induced
RIG-I signaling. 3ABCD results from secondary processing of the
HAV polyprotein at the P2-P3 junction, and is itself subject to
further processing via two distinct pathways, one leading to
production of 3ABC and the other to 3CD (Fig. 7). Both
intermediates contain the catalytically active 3Cpro cysteine
protease domain, but they have distinct cellular localization and
substrate specificities (Fig. 5). 3ABC, due to the presence of a
mitochondrial targeting transmembrane domain in 3A, localizes to
the mitochondrial membrane where it cleaves MAVS (Fig. 5A). In
contrast, 3CD appears to be localized primarily to the perinuclear
ER, and its ability to cleave TRIF is dependent upon its unique
substrate specificity rather than its intracellular localization
(Figs. 5B and 5D).
Our results reveal an unexpected role of the 3D sequence in
modulating the substrate specificity of 3CD. 3Cpro cleavage sites
within the HAV polyprotein, as well as MAVS, contain a
hydrophobic amino acid (Leu, Ile, or Val) at the P4 position
[12,24] that fits into the hydrophobic S4 binding pocket within the
crystal structure of 3Cpro [29,30]. In contrast, both 3CD cleavage
sites within TRIF contain an acidic amino acid residue (Asp-190
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and Glu-551) at the P4 position (Fig. 5C), and therefore do not
conform to the canonical cleavage sequence. A previous study
showed that a peptide substrate with a Glu substitution
(underlined) at the P4 position, Ac-EERTQQSFS-NH2, which is
similar to the TRIF cleavage site EQSQ554, was not cleaved by
3Cpro [31]. Our data suggest that 3CD possesses a unique
substrate specificity that allows it to recognize and hydrolyze
cleavage sites within TRIF that are otherwise relatively resistant to
3Cpro. In support of this notion, we showed that changing the non-
canonical cleavage site at Gln-190 of TRIF to a canonical 3Cpro
cleavage sequence resulted in efficient 3Cpro proteolysis and a
reversal of the order of cleavage at the two sites in TRIF (.5D). A
similar change at the Gln-554 site did not make it fully permissive
for 3Cpro cleavage, however, suggesting that there are other
differences in the substrate specificities of 3Cpro and 3CD. Our
data indicate that the change in substrate specificity of 3CD is
conferred in cis by the 3D sequence (Fig. 3B), although the
structural basis for this remains to be determined.
In addition to their differentiated roles in evading innate
immune responses, 3ABC and 3CD are likely to have specialized
roles in the viral life cycle. 3ABC is a stable intermediate that is
important in processing of the P1-2A segment of the polyprotein
Figure 6. TLR signaling and TRIF regulate cellular permissiveness for HAV. (A) Immunofluorescence microscopy of HAV antigen in Huh7.5-
TLR3, -DTIR, and -Vector cells 5 days after infection of the cells with HAV at an m.o.i. of 1. (B–C) Cells were infected with virus at an m.o.i. of 0.05. Virus
yields were determined in harvests of the entire culture (cells plus supernatant media) after 3 freeze-thaw cycles. Lysates were clarified by brief
centrifugation and supernatants were used for (B) HAV antigen ELISA, or (C) quantal infectivity assay. (D) Paired cultures of Huh7.5-TLR3 and -H539E
cells were inoculated with HAV at m.o.i. = 5 to determine one-step replication kinetics. After 1 hr adsorption, cells were washed extensively with PBS,
and refed with fresh medium. Culture supernatants (extracellular) and cell lysates (intracellular) were harvested at the times indicated and infectious
virus titer determined. (E) Immunoblot showing TRIF expression in PH5CH8 cells transduced with lentivirus expressing TRIF-specific shRNA or non-
targeting (NonT) shRNA. GAPDH served as a loading control. (F) IFN-b promoter activity in cells from panel (E) with (grey bar) and without (black bar)
poly-(I:C) stimulation. (G) HAV-specific immunofluorescence in PH5CH8 cells after depletion of TRIF. Similar antigen expression was observed very
rarely in control cells inoculated in parallel with HAV.
doi:10.1371/journal.ppat.1002169.g006
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required for assembly of the viral capsid [32]. 3CD, based on
studies with other picornaviruses, may play a role in the
uridylyation of the protein primer of RNA synthesis, 3B (VPg)
[33]. The multiple functions of these viral proteins reflect a
strategy used by picornaviruses to create processing intermediates
that are functionally distinct from their mature products
[34,35,36].
The dual targeting of RLR and TLR3 signaling by HAV
3ABCD processing intermediates is reminiscent of the HCV NS3/
4A protease, which disrupts both RIG-I and TLR3 signaling
pathways by proteolytically cleaving the same signaling adaptor
proteins, MAVS and TRIF, respectively [7,8,9]. 3Cpro and NS3/
4A are both chymotrypsin-like proteases with double b-barrel folds
[30,37], but they are not closely related phylogenetically. The
HAV 3Cpro protease has a cysteine nucleophile in its active site,
while NS3/4A has a serine. These viral proteases have very
different substrate specificities, and they cleave MAVS and TRIF
at distinctly different sites [7,8,9,12, and Fig. 3]. The fact that both
of these hepatotropic viruses express proteases targeting these two
critical adaptor molecules is thus a remarkable example of
convergent evolution. It also speaks strongly to the importance
of these signaling pathways in the control of RNA viruses in the
liver. However, since HAV infection is always successfully
controlled by the host (except in rare cases of fulminant disease),
these data indicate that the disruption of RLR and TLR3-
mediated antiviral defenses is not sufficient for a virus to establish
the longterm persistence that typifies most HCV infections. HCV
must possess additional immune evasion strategies to account for
its unique capacity to establish chronic infections.
We demonstrated a minimal gain of permissiveness for HAV
replication in hepatocyte-derived cells in which TLR3 or TRIF
expression was depleted (Fig. 6G), and a reduction in viral antigen
expression in hepatoma cells with active TLR3 signaling (Fig. 6B).
However, these effects were modest, potentially reflecting very
efficient control of TLR3 signaling by 3CD in infected cells such
that TLR3 has little impact on viral replication. Alternatively, it
may be that the primary advantage gained by HAV in
antagonizing TLR3 signaling is impaired production of proin-
flammatory cytokines and reduced inflammation associated with
the infection. TLR3 signaling is critically important to murine host
defense against coxsackievirus B, another picornavirus [38], and it
is plausible that the disruption of TLR3 signaling has significance
beyond impairing the type I IFN response.
The subversion of both RLR and TLR3 signaling likely
contributes to the relatively lengthy, clinically silent incubation
period that precedes acute liver injury in hepatitis A. This period is
Figure 7. Interferon-activating pathways disrupted during HAV infection by 3Cpro precursor-mediated proteolysis of signaling
adaptor proteins. Cytosolic HAV RNA is sensed by RNA helicases (most likely MDA-5) which interact through shared caspase-recruitment domains
(CARDS) with the adaptor protein, MAVS, localized on the mitochondrial outer membrane. This induces formation of a macromolecular signaling
complex that leads to activation of non-canonical (IKKe and TBK-1) and canonical (IKKa/b) kinases of the IkB complex, and subsequent activation of
latent cytoplasmic transcription factors, IRF-3 and NF-kB. These activated transcription factors translocate to the nucleus where they induce the
transcription of IFN-b mRNA, thereby initiating the production of IFNs and ISGs. TLR3 activates these same transcription factors via a parallel signaling
pathway that is initiated upon the sensing of viral dsRNA (or poly-I:C) by TLR3 within an endosomal compartment. Binding of its dsRNA ligand
induces the dimerization of TLR3 and subsequent recruitment of the adaptor protein, TRIF, to its cytoplasmic domain through shared Toll/Interleukin-
1 receptor (TIR) domains. Additional details of these pathways are available elsewhere [45]. Precursors of the HAV 3Cpro cysteine protease block both
signaling pathways by directing cleavage of the critical adaptor proteins, MAVS [12] and, as shown in this communication, TRIF. These processing
intermediates, 3ABC and 3CD, represent products of alternative processing pathways by which 3Cpro is derived from the P2P3 polyprotein fragment
(2B to 3Dpol shown at the top), a product of the primary HAV polyprotein cleavage between 2A/2B [1]. MAVS cleavage by 3ABC is dependent upon
3ABC localization to the mitochondria, while 3CD cleavage of TRIF, as shown here, is dependent upon altered substrate specificity of 3Cpro induced
by its fusion to 3Dpol.
doi:10.1371/journal.ppat.1002169.g007
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characterized by robust viral replication within the liver and
shedding of virus in feces, which reaches a maximum at the onset
of hepatic inflammation [10,39]. The absence of a type I IFN
response in acute infectious hepatitis was hinted at in clinical
studies done almost 40 years ago [40]. Consistent with this, we
recently documented a paucity of type I IFN-dependent ISG
expression (e.g., IFIT-1, ISG15) within the liver of HAV-infected
chimpanzees during the first weeks of infection despite high viral
RNA copy numbers [41]. The cleavage of MAVS and TRIF by
3ABC and 3CD, respectively, provides a partial mechanistic
explanation for this. By dealing a double blow to two major
cellular antiviral response pathways, HAV appears able to block
somatic cell expression of IFN-a/b, thus facilitating its replication.
Yet to be explained is how it evades recognition by plasmacytoid
dendritic cells (pDCs), which may play a significant role in sensing
HCV infection in the liver and generating the strong intrahepatic




HEK 293FT cells, Huh7, Huh-7.5 and Bla-C cells [12] were
cultured in DMEM with 8% FBS. Huh7-TLR3, Huh-7.5-TLR3
and related control cells [13], and HAV-Bla subgenomic replicon
cells were cultured in the same medium supplemented with
blasticidin [12]. The cell culture-adapted HAV strain HM175/18f
[16] was amplified in Huh7 cells; on fetal rhesus kidney FRhK4
cells.
Plasmids and antibodies
pCDNA6-TRIF [7] and pCMV-HA vectors expressing N-
terminally HA-tagged HAV proteins derived from HM-175/18f
virus [12] have been described previously. Similar pCMV-HA
vectors expressing the wild-type HM175 3Cpro and 3CD proteins
were constructed by amplification of the corresponding sequences
from pHAV/8y (Suzanne Emerson, NIAID). Truncations of
TRIF were generated by PCR mutagenesis, and mutations in
TRIF and 3CD constructed by site-directed mutagenesis (Strate-
gene). Other plasmids were obtained from the following sources:
pIFN-b-Luc (Rongtuan Lin, McGill University), pPRD-II-Luc
(Michael Gale, University of Washington), pCMV-b-gal (Clon-
tech), pRL-CMV (Promega), pEF-Bos-TRIF (Kate Fitzgerald,
University of Massachusetts) and pCDNA3-Flag-IKKe (Tom
Maniatis, Harvard University). Antibodies used in these studies
included: anti-TLR3 (Ilkka Julkunen, National Institute for Health
and Welfare, Finland), anti-TRIF S219 (Cell Signaling Technol-
ogy), anti-TRIF aa 4–31 (Alexia), anti-IRF-3 sc-9082 (Santa Cruz),
monoclonal anti-HAV K2-4F2, K3-4C8 (Commonwealth Serum
Laboratories, Victoria, Australia), and 6A5 (John Hughes, Merck,
Sharp & Dohme), anti-HAV 2A (David Sangar, Wellcome
Biotech), anti-3Cpro (Verena Gauss-Muller, University of Lübeck),
anti-ISG15 (Santa Cruz), and anti-HA and anti-Actin (Sigma).
Rabbit anti-TRIF antibody S537-2 was obtained by immunization
of rabbits with recombinant TRIF protein [7].
Transfection and luciferase reporter assays
For protein expression, cells were transfected with plasmid DNA
using Lipofectamine 2000 (Invitrogen) and lysates prepared 20 hrs
later using 1% NP-40 lysis buffer. HAV-infected cells (m.o.i. = 3)
were cultured for 4 days prior to transfection. For luciferase
reporter assays, expression and/or Luc reporter plasmids were
transfected into cells (seeded in triplicate in 96-well format) with an
internal b-galactosidase (pCMV-b-gal) or Renilla luciferase (pRL-
CMV, Promega) transfection control. At 20 hours posttransfec-
tion, when indicated, poly(I:C) (Sigma) was added to the medium
and cells incubated for additional 6 hours. Cells were lysed in
Reporter Lysis Buffer (Promega) and equal quantity of lysate used
for luciferase and b-galactosidase assays (Promega). In experiments
using the Renilla luciferase control, cells were lysed in Passive Lysis
Buffer (Promega) and tested by Dual-Luciferase assay (Promega).
For each sample, the luciferase activity was normalized to the b-
galactosidase or renilla luciferase activity. In the case of poly(I:C)
stimulation, results were presented as fold induction compared to
unstimulated cells. Statistical analysis was performed using two-
tailed Student’s t test.
HAV assays
HAV antigen-specific ELISA was carried out using a post-
convalescent human antibody for capture [44], and a murine
monoclonal antibody (K24F2) for detection. Absorption at 450 nm
was determined on a Synergy (Biotek, Inc) plate reader. The
infrared fluorescent immunofocus assay (IR-FIFA) for infectious
HAV was done using FRhK-4 cells as previously described [12]. For
detection of HAV antigen by immunofluorescence microscopy, cells
were fixed with 4% PFA for 25 min, labeled with murine mAb 6A5
and after extensive washing incubated with goat anti-mouse IgG
Alexa-594 conjugate (Invitrogen).
Expression and purification of GST-3C from E. coli
The 3Cpro coding sequence from HAV strain HM175/18f was
cloned into bacterial expression vector pGEX-4T3 (GE Life
Sciences), fused in-frame with an N-terminal GST tag. For protein
expression, an overnight culture of E. coli strain BL21(DE)
(Novagen) containing the expression construct was diluted 10-fold
and cultured at 37uC for 2 hrs. Expression was induced by
addition of 0.1 mM IPTG and continued culture at 25uC for
3 hrs. Bacterial cells were harvested and lysed in BugBuster
solution (EMD Biosciences) containing 37.5 U/ml Benzonase, 15
KU/ml recombinant lysozyme and 2 mM DTT. GST-3Cpro
fusion protein was purified from the bacterial lysate by affinity
chromatography using the GST MicroSpin Purification Module
(GE Life Sciences) according to the manufacturer’s instructions.
In vitro cleavage assay
Myc-TRIF and its truncated forms were synthesized in vitro and
labeled with [35S]-Met/Cys using T7 Coupled Transcription/
Translation System (TNT, Promega) according to the manufac-
turer’s instructions. Cleavage assays were performed in a 10-ml
mixture containing 1 ml TNT product and 0.5 mM purified GST-
3Cpro in a buffer containing 50 mM Tris-HCl pH 8.0, 2.5 mM
EDTA and 2 mM DTT. Similarly purified GST was used as a
negative control at the same concentration. Reactions were carried
out overnight at 3uC and stopped by addition of an equal volume
of 2X SDS sample buffer. Cleavage products were analyzed by
SDS-PAGE followed by autoradiography.
Immunoprecipitation and immunoblotting
For detection of endogenous TRIF, 1 mg of cell lysate was
immunoprecipitated with 1 mg of rabbit anti-TRIF antibody
S537-2 [7], followed by immunoblotting with anti-TRIF S219.
HA-3CD was detected with a similar method using anti-HA for
immunoprecipitation and anti-3Cpro for immunoblotting.
IRF-3 dimerization
Huh7-TLR3 cells were mock-infected or infected with HAV at
m.o.i. = 5 and cultured for 5 days, then stimulated by the addition
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of poly-(I:C) (50 mg/ml) to the medium for 2 hours and lysed with
1% NP-40 lysis buffer. Cell lysates (10 mg) were mixed with
deoxycholate (DOC) sample buffer (final concentration 1% DOC)
and separated by Tris-Glycine/1% DOC native PAGE. IRF-3
monomer and dimer were detected by immunoblotting with rabbit
anti-IRF-3 sc-9082.
Laser-scanning confocal microscopy
Ectopically expressed Flag-tagged TRIF, 3Cpro and 3ABC, HA-
tagged 3Cpro and 3CD, and V5-tagged 3ABCD were imaged as
described previously [12]. For visualization of poly(I:C)-induced
changes in IRF-3 localization, Huh7-TLR3 cells were grown on
chamber slides, infected at low m.o.i. and cultured for 5 days. Cells
were then mock-stimulated or stimulated with poly-(I:C) (50 mg/
ml) added to the medium for 2 hours, and fixed with 4%
paraformaldehyde. After permeabilization with 0.25% Triton X-
100, the cell monolayer was incubated with rabbit anti-IRF-3 sc-
9082 and murine anti-HAV K3-4C8, followed by secondary
antibodies goat anti-rabbit Alexa Fluor 488 and goat anti-mouse
Alexa Fluor 594 (Invitrogen). Nuclei were counterstained stained
with DAPI. Images were collected using a Leica DMIRB Inverted
Microscope in the Michael Hooker Microscopy Facility.
GenBank accession numbers
HAV strain HM175/18f (including individual HAV proteins),
M59808; wild-type HAV strain HM175, M14707.1; TLR3,
NP_003256; ISG15, NP_005092; TRIF (TICAM-1), NP_891549;
IKKe, NP_054721; IRF-3, NP_001562; MDA5, NP_071451;
RIG-I, O95786; MAVS (IPS-1, Cardif, VISA), Q7Z434; GAPDH,
P04406; Actin, P60709.
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